Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Immunological Methods|January 18, 2006
In vitro and in vivo protein sampling by combined microdialysis and ultrafiltrationA J Rosenbloom, R L Ferris, R Ferris, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localizationR L Ferris, C Hall, N V Sipsas, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteinsR L Ferris, C Buck, S A Hammond, et al.Oncogene|February 16, 2016
EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complexY Lei, B A Kansy, J Li, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2009
Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancersA S Gokhale, B T McLaughlin, J C Flickinger, et al.Oral Oncology|October 1, 2016
Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiationD C Ling, B V Chapman, J Kim, et al.AJNR. American Journal of Neuroradiology|May 4, 2013
Negative predictive value of surveillance PET/CT in head and neck squamous cell cancerM McDermott, M Hughes, T Rath, et al.The Journal of Thoracic and Cardiovascular Surgery|March 1, 1995
Aortic root replacement. Risk factor analysis of a seventeen-year experience with 270 patientsV L Gott, A M Gillinov, R E Pyeritz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2010
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapyV A Passero, B F Branstetter, Y Shuai, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancerR L Ferris, J L Geiger, S Trivedi, et al.Pageof 3